Thursday, January 26, 2017 5:17:30 AM
So if ethanol price > blended gasoline price = RIN has a negative value, assuming that RIN price is the spread between demand price of blended gasoline and ethanol price.
Higher ethanol prices is offset by lower RIN prices, unless gasoline prices increase - then RIN prices remain the same or increases.
Lower ethanol prices is offset by higher RIN prices, unless gasoline prices drops - then RIN doesn't increase.
I know this is a crude understanding, however, one thing seems clear.
Price for blended gasoline is the big driver here.
Price for blended gasoline is not necessarily positive correlated with ethanol prices, but may in fact be positive correlated with RIN prices.
So in terms of revenues, we (PEIX) want gasoline prices to increase (in addition to ethanol prices of course) so that we secure more revenue on RINs.
Finally, bio-gasonline (whatever) and cellulose with RIN factors of 1.5X and 2.5X will dillute the RIN market, and push down prices even more.
Am I totally wrong in my understanding?
Recent ALTO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:13:30 PM
- Alto Ingredients, Inc. Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/06/2024 08:05:21 PM
- Alto Ingredients, Inc. to Release First Quarter 2024 Financial Results on May 6, 2024 • GlobeNewswire Inc. • 04/29/2024 12:30:15 PM
- Alto Ingredients, Inc. Appoints Todd E. Benton as Chief Operating Officer; Michael D. Kandris to Continue to Serve as Director • GlobeNewswire Inc. • 03/21/2024 12:30:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:18:04 PM
- Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:08 PM
- Alto Ingredients, Inc. Enters Letter of Intent with Vault to Advance Carbon Capture and Storage Initiative • GlobeNewswire Inc. • 03/11/2024 08:02:21 PM
- Alto Ingredients, Inc. to Participate in the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/05/2024 01:30:06 PM
- Alto Ingredients, Inc. to Release Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 03/04/2024 01:30:24 PM
- Alto Ingredients, Inc. Publishes Sustainability Summary • GlobeNewswire Inc. • 12/11/2023 01:30:04 PM
- Alto Ingredients, Inc. Extends Term Loan Commitment Period • GlobeNewswire Inc. • 12/06/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:32:32 PM
- Alto Ingredients, Inc. to Participate in Upcoming Conferences • GlobeNewswire Inc. • 11/08/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:19:10 PM
- Alto Ingredients, Inc. Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 11/06/2023 09:05:29 PM
- Alto Ingredients, Inc. to Release Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/30/2023 12:30:00 PM
- Alto Ingredients, Inc. to Present at the LD Micro Main Event XVI • GlobeNewswire Inc. • 09/27/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 09:20:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2023 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2023 08:05:28 PM
- Alto Ingredients, Inc. to Present at the H.C. Wainwright & Co. 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2023 12:30:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2023 08:10:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:16:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:15:54 PM
- Alto Ingredients, Inc. Reports Second Quarter 2023 Results • GlobeNewswire Inc. • 08/07/2023 08:05:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM